Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza.
Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza.
复制标题
对细菌合并感染的非典型反应和持续性中性粒细胞性支气管肺泡炎症将危重的 COVID-19 与流感区分开来。
DOI:
10.1172/jci.insight.155055
复制
发表时间:
2022-01-11
期刊:
影响因子:
8
通讯作者:
Proost P
中科院分区:
文献类型:
--
作者:
Cambier S;Metzemaekers M;de Carvalho AC;Nooyens A;Jacobs C;Vanderbeke L;Malengier-Devlies B;Gouwy M;Heylen E;Meersseman P;Hermans G;Wauters E;Wilmer A;CONTAGIOUS Consortium;Schols D;Matthys P;Opdenakker G;Marques RE;Wauters J;Vandooren J;Proost P
Neutrophils are recognized as important circulating effector cells in the pathophysiology of severe coronavirus disease 2019 (COVID-19). However, their role within the inflamed lungs is incompletely understood. Here, we collected bronchoalveolar lavage (BAL) fluids and parallel blood samples of critically ill COVID-19 patients requiring invasive mechanical ventilation and compared BAL fluid parameters with those of mechanically ventilated patients with influenza, as a non–COVID-19 viral pneumonia cohort. Compared with those of patients with influenza, BAL fluids of patients with COVID-19 contained increased numbers of hyperactivated degranulating neutrophils and elevated concentrations of the cytokines IL-1β, IL-1RA, IL-17A, TNF-α, and G-CSF; the chemokines CCL7, CXCL1, CXCL8, CXCL11, and CXCL12α; and the protease inhibitors elafin, secretory leukocyte protease inhibitor, and tissue inhibitor of metalloproteinases 1. In contrast, α-1 antitrypsin levels and net proteolytic activity were comparable in COVID-19 and influenza BAL fluids. During antibiotic treatment for bacterial coinfections, increased BAL fluid levels of several activating and chemotactic factors for monocytes, lymphocytes, and NK cells were detected in patients with COVID-19 whereas concentrations tended to decrease in patients with influenza, highlighting the persistent immunological response to coinfections in COVID-19. Finally, the high proteolytic activity in COVID-19 lungs suggests considering protease inhibitors as a treatment option.
登录
查看更多内容
影响因子:
12.3
作者:
Aschenbrenner AC;Mouktaroudi M;Krämer B;Oestreich M;Antonakos N;Nuesch-Germano M;Gkizeli K;Bonaguro L;Reusch N;Baßler K;Saridaki M;Knoll R;Pecht T;Kapellos TS;Doulou S;Kröger C;Herbert M;Holsten L;Horne A;Gemünd ID;Rovina N;Agrawal S;Dahm K;van Uelft M;Drews A;Lenkeit L;Bruse N;Gerretsen J;Gierlich J;Becker M;Händler K;Kraut M;Theis H;Mengiste S;De Domenico E;Schulte-Schrepping J;Seep L;Raabe J;Hoffmeister C;ToVinh M;Keitel V;Rieke G;Talevi V;Skowasch D;Aziz NA;Pickkers P;van de Veerdonk FL;Netea MG;Schultze JL;Kox M;Breteler MMB;Nattermann J;Koutsoukou A;Giamarellos-Bourboulis EJ;Ulas T;German COVID-19 Omics Initiative (DeCOI)
通讯作者:
German COVID-19 Omics Initiative (DeCOI)
影响因子:
3.1
作者:
Pandolfi L;Fossali T;Frangipane V;Bozzini S;Morosini M;D'Amato M;Lettieri S;Urtis M;Di Toro A;Saracino L;Percivalle E;Tomaselli S;Cavagna L;Cova E;Mojoli F;Bergomi P;Ottolina D;Lilleri D;Corsico AG;Arbustini E;Colombo R;Meloni F
通讯作者:
Meloni F
影响因子:
6.9
作者:
Houghton, A. McGarry
通讯作者:
Houghton, A. McGarry
DOI:
10.1016/j.xcrm.2021.100229
发表时间:
2021-04-20
期刊:
Cell reports. Medicine
影响因子:
--
作者:
Buehler PK;Zinkernagel AS;Hofmaenner DA;Wendel Garcia PD;Acevedo CT;Gómez-Mejia A;Mairpady Shambat S;Andreoni F;Maibach MA;Bartussek J;Hilty MP;Frey PM;Schuepbach RA;Brugger SD
通讯作者:
Brugger SD
影响因子:
8.3
作者:
Cardinal-Fernandez, Pablo;Lorente, Jose A.;Matute-Bello, Gustavo
通讯作者:
Matute-Bello, Gustavo